Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diffuse Large B Cell Lymphoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Objective to evaluate the efficacy and safety of maintenance therapy with Chidamide in patients With Hepatitis B Virus?HBV?Positive Diffuse Large B-cell Lymphoma?DLBCL? with complete response after completion of prior chemotherapy, so as to provide the basis for the application of Chidamide in HBV p...
Objective to evaluate the efficacy and safety of maintenance therapy with Chidamide in patients With Hepatitis B Virus?HBV?Positive Diffuse Large B-cell Lymphoma?DLBCL? with complete response after completion of prior chemotherapy, so as to provide the basis for the application of Chidamide in HBV positive DLBCL
Tracking Information
- NCT #
- NCT04661943
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon